Archive · 18 Aug 2025
Indian Drug Makers Face Challenges in Fight Against Fake Medicines
Imagine some medicines are like toys, but some are fake or not made well.
These fakes can make people sick.
India's government checks medicines, but some companies make fake ones.
To fight this, some companies put special codes and packaging on their medicines so you can tell if they're real.
They also tell people how to spot fakes.
But, it's not easy to stop the fakes because some people don't know how to check, and it's hard to catch all the fake ones.
To make things better, the government, medicine makers, and others need to work together to keep everyone safe.
Counterfeit and substandard drugs erode patient trust and can endanger lives.
Several widely used medicines have been flagged as 'not of standard quality' by India's drug regulator.
Some drug makers are using QR codes, special packaging, and public awareness campaigns to combat fake drugs.
Weak enforcement, distribution gaps, and limited consumer awareness contribute to the persistence of counterfeit drugs.
A stronger, coordinated effort involving regulators, law enforcement, and pharmaceutical companies is needed.
- Who
- Indian drug makers, regulatory bodies like CDSCO, and consumers are all involved.
- What
- Counterfeit and substandard drugs are a major concern in India, eroding patient trust and potentially endangering lives.
- When
- Over the past year, several widely used medicines were flagged.
- Where
- India
- Why
- Counterfeit drugs compromise treatment outcomes and patient safety, necessitating efforts to ensure medicine authenticity.
Drug Makers' Actions
Consumer Impact
Proactive vs. Inactive
Drug Makers' Actions
Some drug makers are proactively implementing measures like QR codes and special packaging to combat counterfeit drugs.
Consumer Impact
Some drug companies have not responded with their safeguard measures.
- Regulator
- CDSCO (Central Drugs Standard Control Organisation)
- Focus
- Combating counterfeit and substandard drugs
- Action
- QR codes are mandatory for 300 pharmaceutical brands.
- Companies Involved
- GSK, Alkem, Mankind Pharma, Cipla, Glenmark, Sun Pharma
- Challenges
- Weak enforcement and limited consumer awareness
- Solutions
- QR codes, special packaging, public awareness campaigns.